Altium Capital Management »

Catalyst Pharmaceutical Partners shares owned by Altium Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.0M 500k 15.94

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Xenon Pharmaceuticals (XENE)
Viking Therapeutics Put Put Option
Advisorshares Tr Call Call Option
Axsome Therapeutics (AXSM)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Xtant Med Hldgs Com New (XTNT)
Catalyst Pharmaceutical Partners (CPRX)
Intra Cellular Therapies (ITCI)
Biohaven (BHVN)
Viking Therapeutics (VKTX)
Olema Pharmaceuticals (OLMA)
Savara (SVRA)

View all positions for Altium Capital Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners